| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rachel L Gunn, Elizabeth R Aston, Alexander W Sokolovsky, Helene R White, Kristina M Jackso. Complex cannabis use patterns: Associations with cannabis consequences and cannabis use disorder symptomatology. Addictive behaviors. vol 105. 2021-02-26. PMID:32044680. |
this study sought to: 1) classify cannabis users into groups based on their use of the full range of cannabis products, and 2) examine user group differences on demographics, cannabis consequences and cannabis use disorder (cud) symptomatology. |
2021-02-26 |
2023-08-13 |
Not clear |
| Daniel B Rosoff, Joyce Yoo, Falk W Lohof. A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19. medRxiv : the preprint server for health sciences. 2021-02-24. PMID:33594380. |
genetically predicted cannabis use disorder (cud) was associated with increased bronchitis risk (or=1.078, 95% ci, 1.020-1.128, p-value=0.007). |
2021-02-24 |
2023-08-13 |
Not clear |
| Mallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, Will M Aklin, Alan J Budney, Kathleen M Carroll, Deepak Cyril D'Souza, Robert H Dworkin, Kevin M Gray, Deborah S Hasin, Dustin C Lee, Bernard Le Foll, Frances R Levin, Joshua A Lile, Barbara J Mason, Aimee L McRae-Clark, Ivan Montoya, Erica N Peters, Tatiana Ramey, Dennis C Turk, Ryan Vandrey, Roger D Weiss, Eric C Strai. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and alcohol dependence. vol 212. 2021-02-22. PMID:32360455. |
there is considerable variability in the use of outcome measures in clinical trials for cannabis use disorder (cud), and a lack of consensus regarding optimal outcomes may have hindered development and approval of new pharmacotherapies. |
2021-02-22 |
2023-08-13 |
Not clear |
| Mallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, Will M Aklin, Alan J Budney, Kathleen M Carroll, Deepak Cyril D'Souza, Robert H Dworkin, Kevin M Gray, Deborah S Hasin, Dustin C Lee, Bernard Le Foll, Frances R Levin, Joshua A Lile, Barbara J Mason, Aimee L McRae-Clark, Ivan Montoya, Erica N Peters, Tatiana Ramey, Dennis C Turk, Ryan Vandrey, Roger D Weiss, Eric C Strai. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and alcohol dependence. vol 212. 2021-02-22. PMID:32360455. |
the primary recommendation is that sustained abstinence from cannabis should not be considered the primary outcome for all cud clinical trials as it has multiple limitations. |
2021-02-22 |
2023-08-13 |
Not clear |
| Mallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, Will M Aklin, Alan J Budney, Kathleen M Carroll, Deepak Cyril D'Souza, Robert H Dworkin, Kevin M Gray, Deborah S Hasin, Dustin C Lee, Bernard Le Foll, Frances R Levin, Joshua A Lile, Barbara J Mason, Aimee L McRae-Clark, Ivan Montoya, Erica N Peters, Tatiana Ramey, Dennis C Turk, Ryan Vandrey, Roger D Weiss, Eric C Strai. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and alcohol dependence. vol 212. 2021-02-22. PMID:32360455. |
four primary agenda items for future research are identified to expedite development of improved clinical outcome assessments for this toolkit: (1) determine whether minimally invasive biologic assays could identify an acute level of cannabis use associated with psychomotor impairment or other cannabis-related harms; (2) create an indicator of quantity of cannabis use that is consistent across product types; (3) examine the presence of cannabis-specific functional outcomes; and (4) identify an optimal duration to assess changes in cud diagnostic criteria. |
2021-02-22 |
2023-08-13 |
Not clear |
| Emese Kroon, Lauren Kuhns, Eva Hoch, Janna Cousij. Heavy cannabis use, dependence and the brain: a clinical perspective. Addiction (Abingdon, England). vol 115. issue 3. 2021-02-18. PMID:31408248. |
to summarize and evaluate our knowledge of the relationship between heavy cannabis use, cannabis use disorder (cud) and the brain. |
2021-02-18 |
2023-08-13 |
Not clear |
| Jesse R Cougle, Katherine A McDermott, Jahn K Hakes, Keanan J Joyne. Personality disorders and social support in cannabis dependence: A comparison with alcohol dependence. Journal of affective disorders. vol 265. 2021-02-15. PMID:31957689. |
cannabis use disorder (cud) has been linked to personality disorders (pds) and interpersonal problems, though these relationships have been understudied. |
2021-02-15 |
2023-08-13 |
Not clear |
| Navin Kumar, Cheneal Puljević, Jason Ferris, Adam Winstock, Monica J Barrat. Cannabis use patterns at the dawn of US cannabis reform. Journal of cannabis research. vol 1. issue 1. 2021-02-06. PMID:33526080. |
in the united states (us), three in 10 cannabis users develop cannabis use disorder (cud). |
2021-02-06 |
2023-08-13 |
human |
| Navin Kumar, Cheneal Puljević, Jason Ferris, Adam Winstock, Monica J Barrat. Cannabis use patterns at the dawn of US cannabis reform. Journal of cannabis research. vol 1. issue 1. 2021-02-06. PMID:33526080. |
to provide understanding around cud, it is necessary to detail granular cannabis usage preferences, as some risk from cannabis use may be mitigated through informed behavioral choices by users. |
2021-02-06 |
2023-08-13 |
human |
| Navin Kumar, Cheneal Puljević, Jason Ferris, Adam Winstock, Monica J Barrat. Cannabis use patterns at the dawn of US cannabis reform. Journal of cannabis research. vol 1. issue 1. 2021-02-06. PMID:33526080. |
with the rapidly developing us cannabis market, possibly problematic usage patterns may indicate potential for cud especially within young men. |
2021-02-06 |
2023-08-13 |
human |
| Magdalena Cerdá, Christine Mauro, Ava Hamilton, Natalie S Levy, Julián Santaella-Tenorio, Deborah Hasin, Melanie M Wall, Katherine M Keyes, Silvia S Martin. Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016. JAMA psychiatry. vol 77. issue 2. 2021-02-02. PMID:31722000. |
little is known about changes in marijuana use and cannabis use disorder (cud) after recreational marijuana legalization (rml). |
2021-02-02 |
2023-08-13 |
Not clear |
| A Dunkerbeck Van Kampen, J Cousijn, C Engel, M Rinck, B A G Dijkstr. Attentional bias, craving and cannabis use in an inpatient sample of adolescents and young adults diagnosed with cannabis use disorder: The moderating role of cognitive control. Addictive behaviors. vol 100. 2021-01-15. PMID:31605838. |
the present cross-sectional study was designed to replicate and extend previous research by investigating the relationships between attentional bias, craving, cognitive control and (severity of) cannabis use in a sample of inpatient adolescents and young adults (aged 18-30) diagnosed with cud according to dsm-5. |
2021-01-15 |
2023-08-13 |
human |
| Shikha Prashad, Ryan P Hammonds, Amanda L Wiese, Amber L Milligan, Francesca M Filbe. Sex-related differences in subjective, but not neural, cue-elicited craving response in heavy cannabis users. Drug and alcohol dependence. vol 209. 2021-01-12. PMID:32113057. |
studies indicate that female cannabis users progress through the milestones of cannabis use disorder (cud) more quickly than male users, likely due to greater subjective craving response in women relative to men. |
2021-01-12 |
2023-08-13 |
Not clear |
| Deborah Hasin, Claire Wals. Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. Journal of clinical medicine. vol 10. issue 1. 2021-01-12. PMID:33374666. |
therefore, the primary aim of this narrative review is to provide a concise overview of the literature on the comorbidity of cannabis use and cannabis use disorder (cud) with other substance use and psychiatric disorders, and to use this information to accurately guide future directions for the field. |
2021-01-12 |
2023-08-13 |
Not clear |
| Julie Aamand Olesen, Christine Merrild Posselt, Chalotte Heinsvig Poulsen, Merete Nordentoft, Carsten Hjorthø. Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls. Psychological medicine. vol 50. issue 3. 2020-12-31. PMID:30880659. |
we aimed to investigate whether cannabis use disorders (cud) would decrease the risk of incident disorders of the digestive organs, in people with schizophrenia and population controls. |
2020-12-31 |
2023-08-13 |
Not clear |
| M Taylor, J Cousijn, F Filbe. Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies. Current addiction reports. vol 6. issue 4. 2020-12-17. PMID:33312839. |
this review aims to summarize and critically evaluate the current literature on the associations between individual and socio-cultural factors that increase risk for cannabis use disorder (cud), and policy change. |
2020-12-17 |
2023-08-13 |
Not clear |
| Liangsuo Ma, Joel L Steinberg, James M Bjork, Qin Wang, John M Hettema, Antonio Abbate, F Gerard Moelle. Altered Effective Connectivity of Central Autonomic Network in Response to Negative Facial Expression in Adults With Cannabis Use Disorder. Biological psychiatry. Cognitive neuroscience and neuroimaging. vol 5. issue 1. 2020-12-04. PMID:31345781. |
we aimed to obtain evidence to determine whether neural connectivity of the central autonomic network is altered in individuals with cannabis use disorder (cud) when they are exposed to negative emotional stimuli. |
2020-12-04 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Kevin M Gray, Marilyn A Huestis, Lindsay M Squeglia, Nathaniel L Baker, Erin A McClur. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Current addiction reports. vol 6. issue 4. 2020-12-01. PMID:32133273. |
cannabis abstinence traditionally is the primary outcome in cannabis use disorder (cud) treatment trials. |
2020-12-01 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Kevin M Gray, Marilyn A Huestis, Lindsay M Squeglia, Nathaniel L Baker, Erin A McClur. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Current addiction reports. vol 6. issue 4. 2020-12-01. PMID:32133273. |
due to the changing legality of cannabis, patient goals, and preliminary evidence that suggests individuals who reduce their cannabis use may show functional improvements, cannabis reduction is a desirable alternative outcome in cud trials. |
2020-12-01 |
2023-08-13 |
Not clear |
| Amaya Pankaj, Kosisochukwu Oraka, Emmanuelle J Caraballo-Rivera, Munazza Ahmad, Shaheer Zahid, Sadaf Munir, Gayathri Gurumurthy, Onose Okoeguale, Shikha Verma, Rikinkumar S Pate. Recreational Cannabis Use and Risk of Prescription Opioid Overdose: Insights from Pediatric Inpatients. Cureus. vol 12. issue 10. 2020-11-24. PMID:33224654. |
objectives our first goal is to evaluate the prevalence of hospital admissions for prescription opioid overdose (pod) in pediatric inpatients, and next goal is to measure the independent association between cannabis use disorders (cud) and pod. |
2020-11-24 |
2023-08-13 |
Not clear |